Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-2-6
pubmed:abstractText
IL-2-induced vascular leak syndrome (VLS) is an important mechanism explaining the toxic effects of this cytokine and limiting its therapeutic use. We previously characterized a mouse model of IL-2-induced pulmonary VLS used to demonstrate that NK lymphocytes are involved in early/acute phase VLS (after one IL-2 injection). We also showed that NK cells and polymorphonuclear neutrophils (PMN) are involved in the late/chronic phase of the syndrome (after four daily IL-2 injections). In this study we use our mouse model to evaluate the role played by the IL-2 receptor (IL-2R) in VLS induction. Mouse and human IL-2R are different since the mouse IL-2Rbeta chain does not recognize IL-2. Here, we compare the acute and late VLS responses in human IL-2Rbeta transgenic and C57BL/6 wild type mice. Parameters linked to early phase VLS (bronchoconstriction and PMN mobilization) are enhanced in human IL-2Rbeta transgenic mice. By contrast, parameters used to measure late events (protein leakage and edema) are similar in human IL-2Rbeta transgenic mice and C57BL/6 wild type animals. However, after four IL-2 injections, the cellular content of the bronchoalveolar lavage fluids was different between the two types of animals. This study also characterizes a humanized animal model that could be further used to study human IL-2 activity and side effects in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1043-4666
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
280-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16378732-Airway Resistance, pubmed-meshheading:16378732-Animals, pubmed-meshheading:16378732-Bronchoalveolar Lavage Fluid, pubmed-meshheading:16378732-Capillary Leak Syndrome, pubmed-meshheading:16378732-Cell Count, pubmed-meshheading:16378732-Cell Movement, pubmed-meshheading:16378732-Gene Expression, pubmed-meshheading:16378732-Humans, pubmed-meshheading:16378732-Interleukin-2, pubmed-meshheading:16378732-Interleukin-2 Receptor beta Subunit, pubmed-meshheading:16378732-Lung, pubmed-meshheading:16378732-Lymphocytes, pubmed-meshheading:16378732-Male, pubmed-meshheading:16378732-Methacholine Chloride, pubmed-meshheading:16378732-Mice, pubmed-meshheading:16378732-Mice, Inbred C57BL, pubmed-meshheading:16378732-Mice, Transgenic, pubmed-meshheading:16378732-Neutrophils, pubmed-meshheading:16378732-Organ Size, pubmed-meshheading:16378732-Peroxidase, pubmed-meshheading:16378732-Plethysmography, Whole Body, pubmed-meshheading:16378732-Proteins, pubmed-meshheading:16378732-Receptors, Interleukin-2
pubmed:year
2005
pubmed:articleTitle
Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome.
pubmed:affiliation
Unité de Pharmacologie Cellulaire, Institut Pasteur, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't